Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of icaritin derivative IC2 as an SCD-1 inhibitor with anti-breast cancer properties through induction of cell apoptosis
Chen Yang, Yi-Yuan Jin, Jie Mei, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 17

Showing 17 citing articles:

Downregulation of Gldc attenuates myocardial ischemia reperfusion injury in vitro by modulating Akt and NF-κB signalings
Lian Shuang, Youle Su, Yue Zhang
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Antineoplastic effects of icaritin: molecular mechanisms and applications
Piao Luo, Liyang Zhang, Guangqing Cheng, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 2
Open Access
Lipid Metabolism in Breast Cancer: From Basic Research to Clinical Application
Xiangyu Huang, Bowen Liu, Songjie Shen
Cancers (2025) Vol. 17, Iss. 4, pp. 650-650
Open Access
Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment
Mengting Wan, Shuaikang Pan, Benjie Shan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Stearoyl-CoA Desaturase 1 as a Therapeutic Biomarker: Focusing on Cancer Stem Cells
Jin‐Young Min, Do‐Hee Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8951-8951
Open Access | Times Cited: 13
New insights into the anticancer therapeutic potential of icaritin and its synthetic derivatives
Octavio D. Reyes‐Hernández, Gabriela Figueroa‐González, Laura Itzel Quintas‐Granados, et al.
Drug Development Research (2024) Vol. 85, Iss. 2
Closed Access | Times Cited: 4
Icaritin Derivative IC2 Induces Cytoprotective Autophagy of Breast Cancer Cells via SCD1 Inhibition
Yixuan Wang, Yi-Yuan Jin, Jie Wang, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1109-1109
Open Access | Times Cited: 11
Comprehensive analysis of stearoyl-coenzyme A desaturase in prostate adenocarcinoma: insights into gene expression, immune microenvironment and tumor progression
Jie Wang, Ying Liang, He Xiong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Theoretical Framework and Emerging Challenges of Lipid Metabolism in Cancer
Qiuying Gu, Yuan Wang, Ping Yi, et al.
Seminars in Cancer Biology (2024)
Open Access | Times Cited: 2
Traditional Chinese Medicine for Breast Cancer: A Review
Rui-Qi Feng, Dehui Li, Xukuo Liu, et al.
Breast Cancer Targets and Therapy (2023) Vol. Volume 15, pp. 747-759
Open Access | Times Cited: 7
Systematic analysis of fatty acid desaturases in breast invasive carcinoma: The prognosis, gene mutation, and tumor immune microenvironment
Jie Wang, Qian Zhang, Duanrui Zhou, et al.
Medicine (2024) Vol. 103, Iss. 25, pp. e38597-e38597
Open Access | Times Cited: 1
The emerging role of long non-coding RNAs in renal cell carcinoma progression and clinical therapy via targeting metabolic regulation
Xingyu Gao, Haiying Zhang, Chang Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Effect of Icaritin on non-small cell lung cancer NCI-H1299 cells
Lixia Hou, Xinru Feng, Bo Xiao, et al.
Transactions on Cancer (2024) Vol. 5, Iss. 1
Open Access
Icariside II in NSCLC and COVID‐19: Network pharmacology and molecular docking study
Qing Kong, Huahe Zhu, Jingcheng Dong, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 7
Closed Access
An insight into advances and challenges in the development of potential stearoyl Co-A desaturase 1 inhibitors
Shivani Kirad, Sonakshi Puri, Perinkulam Ravi Deepa, et al.
RSC Advances (2024) Vol. 14, Iss. 41, pp. 30487-30517
Open Access
Lipid droplet formation induced by icaritin derivative IC2 promotes a combination strategy for cancer therapy
Guosheng Wu, Ying Liang, Qian Zhang, et al.
Research Square (Research Square) (2024)
Closed Access
Lipid droplet formation induced by icaritin derivative IC2 promotes a combination strategy for cancer therapy
Guosheng Wu, Ying Liang, Qian Zhang, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access
Page 1

Scroll to top